Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
227.87+6.37 (+2.88%)
As of 11:48AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
No. of analysts6355
Avg. Estimate-1.490.78-5.717.89
Low estimate-2.16-1.59-6.220.35
High estimate-0.682.82-4.7733.86
Year ago EPS-1.13-0.58-5.51-5.7
Revenue estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
No. of analysts6265
Avg. Estimate304.88M360.35M500.87M3.11B
Low estimate123M296.7M319M1.07B
High estimate492M424M687.94M4.7B
Year ago sales8.82M3.38M18.66M500.87M
Sales growth (year/est)3,358.30%10,570.70%2,583.90%520.80%
Earnings history30/12/201930/03/202029/06/202029/09/2020
Est. EPS-1.06-0.7-0.421.73
Actual EPS-1.13-0.58-0.3-3.21
Difference-0.070.120.12-4.94
Surprise %-6.60%17.10%28.60%-285.50%
EPS trendCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
Current estimate-1.490.78-5.717.89
7 days ago-1.152.93-5.2818.81
30 days ago-1.313.04-5.4917.64
60 days ago-1.313.04-5.4917.64
90 days ago-1.13.04-5.414.4
EPS revisionsCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVAXIndustrySector(s)S&P 500
Current qtr.-31.90%N/AN/AN/A
Next qtr.234.50%N/AN/AN/A
Current year-3.40%N/AN/AN/A
Next year413.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A